Outcome Evaluation for Burn Scar Therapy-laser and Surgery in Patients in Formosa Fun Coast Explosion

计划入组 8 人 · 首次发布于 2019 年 4 月 22 日

Evaluate the Efficacy and Safety of "Formosa 1-Breath Free (NRICM101) " in Subjects With the Symptoms of COVID-19 or Influenza-like Disease

计划入组 170 人 · 首次发布于 2023 年 12 月 19 日

Safety and Dose-Response of Bletilla Formosana in Prediabetic Subjects

计划入组 94 人 · 首次发布于 2026 年 7 月 15 日

Formosa 1-Breath Free

Ado-trastuzumab emtansine biosimilar (Formosa Pharmaceuticals)

Camphor leaf oil

FORMOSA PHARMACEUTICALS, INC.

Taiwan

INSTITUTO BRASILEIRO DE CONTROLE DO CANCER

Brazil

FOREMOST FARMS USA COOPERATIVE

United States

Formosa Pharmaceuticals Partners with Singapore Eye Research Institute to Develop Advanced Ophthalmic Formulations

Formosa Pharmaceuticals Secures Exclusive License for Novel Bispecific ADC Targeting EGFR/ROR1 Solid Tumors

Formosa Pharmaceuticals Expands Global Reach of FDA-Approved Eye Surgery Treatment Through ASEAN Partnership